Q2 2025 Earnings Conference Call July 17, 2025 4:00 AM ETCompany ParticipantsChristian Cederholm - CEO, President ...

Excitement among those who happen to love women’s football continues to mount as the 2025 UEFA Women’s European Championship ...

Excitement among those who happen to love women’s football continues to mount as the 2025 UEFA Women’s European Championship ...

Sunday's battering of Wales allowed the likes of Lauren James, Alessia Russo and Ella Toone to get some rest - they'll all be ready to go again ...

And is there anything that the city and the electric utility could be doing to decrease that likelihood – or, at least, ...

The phase 3 CONTACT-02 study was designed to evaluate the efficacy and safety of cabozantinib plus atezolizumab versus ARPI switch in patients with mCRPC and measurable extrapelvic soft-tissue ...

What is today’s moon phase? As of Thursday, July 3, the moon phase is Waxing Gibbous. According to NASA's Daily Moon Observation, 57% of the moon will be lit up and visible to us on Earth.

Topline results were announced from a phase 3 study evaluating secukinumab in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

SMU has partnered with Scout, an innovative financial technology company built for athletes and university administrators, to lay the groundwork for a new era of student-athlete support. Through this ...

Other parts of HB 135 still take effect, cutting non-emergency care and social services like shelters, soup kitchens, and food aid for undocumented immigrants.

Panelists discuss the EMBER-3 trial, which evaluated single-agent oral selective estrogen receptor degrader (SERD) imlunestrant vs standard endocrine therapy and the combination of imlunestrant with ...

Panelists discuss the SERENA-6 trial evaluating camizestrant, which uniquely enrolled patients with molecularly detected ESR1 mutations before clinical progression, showing that early switching to ...